Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Obeid

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Journal for Immunotherapy of Cancer|October 23, 2021
<sup>68</sup>Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditisSarah Boughdad, Sofiya Latifyan, Craig Fenwick, et al.
Nature Medicine|December 26, 2006
Calreticulin exposure dictates the immunogenicity of cancer cell deathMichel Obeid, Antoine Tesniere, François Ghiringhelli, et al.
Revue Medicale Suisse|May 15, 2025
[Adverse effects of new therapeutic approaches in thoracic oncology]Almaz Sammya, Clément Normand, Nicolas Desbaillets, et al.
Nature Reviews. Clinical Oncology|May 17, 2019
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceFilipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, et al.
The Journal of Experimental Medicine|December 21, 2005
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell deathNoelia Casares, Marie O Pequignot, Antoine Tesniere, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Journal for Immunotherapy of Cancer|November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational studyFangwen Zou, David Faleck, Anusha Thomas, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Journal for Immunotherapy of Cancer|October 23, 2021
<sup>68</sup>Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditisSarah Boughdad, Sofiya Latifyan, Craig Fenwick, et al.
Nature Medicine|December 26, 2006
Calreticulin exposure dictates the immunogenicity of cancer cell deathMichel Obeid, Antoine Tesniere, François Ghiringhelli, et al.
Revue Medicale Suisse|May 15, 2025
[Adverse effects of new therapeutic approaches in thoracic oncology]Almaz Sammya, Clément Normand, Nicolas Desbaillets, et al.
Nature Reviews. Clinical Oncology|May 17, 2019
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceFilipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, et al.
The Journal of Experimental Medicine|December 21, 2005
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell deathNoelia Casares, Marie O Pequignot, Antoine Tesniere, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Journal for Immunotherapy of Cancer|November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational studyFangwen Zou, David Faleck, Anusha Thomas, et al.
Frontiers in Oncology|December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patientsMichel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Pageof 5